What Is Rosacea and How Does It Develop?

Rosacea is a chronic inflammatory skin condition affecting approximately 16 million Americans, characterized by persistent facial redness, visible blood vessels, and inflammatory bumps primarily on the central face. It has four recognized subtypes and involves neurovascular dysregulation, immune system activation, and Demodex mite overpopulation (Source: National Rosacea Society).

Rosacea has four recognized subtypes: erythematotelangiectatic (persistent redness and visible blood vessels), papulopustular (redness with inflammatory bumps resembling acne), phymatous (skin thickening, most notably rhinophyma of the nose), and ocular (eye involvement including dryness, grittiness, and eyelid inflammation). Many patients have features of more than one subtype simultaneously, and the condition tends to progress through stages if left untreated.

The pathophysiology of rosacea involves multiple interconnected mechanisms. Neurovascular dysregulation causes blood vessels to dilate excessively in response to triggers. The innate immune system produces excessive cathelicidin (LL-37), an antimicrobial peptide that promotes inflammation and angiogenesis in rosacea skin. Demodex folliculorum mites, found in higher numbers on rosacea-affected skin, may trigger immune responses and carry bacteria that worsen inflammation.

Risk factors include fair skin (Fitzpatrick types I-II), Northern European ancestry, female sex (though men tend to develop more severe disease), family history, and age typically between 30 and 60 years. The National Rosacea Society estimates that most patients experience their first symptoms between ages 30 and 50, though rosacea can occur at any age.

NRS estimates rosacea affects approximately 16 million Americans

How Should You Manage Rosacea?

Identify and avoid your personal triggers, establish a gentle skincare routine with mineral sunscreen, use prescribed topical treatments consistently, and consider laser therapy for persistent redness and visible blood vessels. A dermatologist can create a personalized treatment plan based on your rosacea subtype.

Start with trigger identification using a diary. The National Rosacea Society's most commonly reported triggers are sun exposure (81%), emotional stress (79%), hot weather (75%), wind (57%), heavy exercise (56%), alcohol (52%), hot baths (51%), cold weather (46%), spicy foods (45%), and humidity (44%). Once identified, avoidance of top triggers significantly reduces flare frequency.

A rosacea-friendly skincare routine includes a gentle, fragrance-free cleanser, moisturizer with ceramides and/or niacinamide, and mineral sunscreen (zinc oxide or titanium dioxide) SPF 30+. Chemical sunscreens can irritate rosacea-prone skin. Apply all products gently without rubbing. Green-tinted color-correcting primers can help camouflage redness. Introduce new products one at a time with a 2-week trial period.

NRS survey identified sun exposure (81%) and stress (79%) as top rosacea triggers

What Prescription Treatments Are Available?

Topical treatments include metronidazole (anti-inflammatory), azelaic acid (anti-inflammatory and antimicrobial), ivermectin (targets Demodex mites), and brimonidine gel (alpha-agonist vasoconstrictor for redness). Oral treatments include low-dose doxycycline (anti-inflammatory dose) for moderate-severe papulopustular rosacea. Laser therapy treats vascular components.

Strong EvidenceHead-to-head RCTs demonstrate ivermectin superiority; multiple RCTs support all listed treatments.

For papulopustular rosacea, topical ivermectin 1% cream (Soolantra) has emerged as a highly effective first-line option, showing superior efficacy to topical metronidazole in head-to-head trials. Applied once daily, it targets both inflammatory papules and the Demodex folliculorum mite implicated in rosacea pathogenesis. Azelaic acid 15% gel (Finacea) is another effective option with additional benefits for post-inflammatory pigmentation.

For persistent background erythema, brimonidine 0.33% gel (Mirvaso) and oxymetazoline 1% cream (Rhofade) provide temporary vasoconstriction reducing visible redness for 8-12 hours. These are used as-needed for social situations or daily maintenance. Pulsed dye laser (PDL) and intense pulsed light (IPL) treatments provide more lasting reduction of telangiectasia and background redness, typically requiring 2-4 sessions with maintenance treatments every 6-12 months.

Topical ivermectin showed superior efficacy to metronidazole in head-to-head trials

What Are the Complications if Rosacea Is Left Untreated?

Untreated rosacea typically progresses from intermittent flushing to persistent redness, then to inflammatory bumps, and potentially to permanent skin thickening (phymatous changes). Ocular rosacea can cause corneal damage and vision problems. The visible nature of the condition also significantly impacts mental health and quality of life.

Moderate EvidenceObservational studies and clinical guidelines document progressive nature of untreated rosacea.

The most visible complication of untreated rosacea is rhinophyma — progressive enlargement and distortion of the nose due to sebaceous gland hyperplasia and fibrosis. While commonly associated with rosacea, rhinophyma affects only a small percentage of patients, predominantly men. Once established, rhinophyma requires surgical or laser intervention to correct [3]. Phymatous changes can also affect the chin (gnathophyma), forehead (metophyma), ears (otophyma), and eyelids (blepharophyma).

Ocular rosacea is an underdiagnosed complication affecting up to 50 percent of rosacea patients. Without treatment, chronic eyelid inflammation (blepharitis) and meibomian gland dysfunction can lead to corneal erosion, corneal neovascularization, and in rare cases, vision loss. Any rosacea patient with persistent eye symptoms should be referred to an ophthalmologist for evaluation.

With consistent treatment — trigger avoidance, gentle skincare, topical medications, and laser therapy as needed — rosacea progression can be halted and many patients achieve long periods of remission.

Rhinophyma requires surgical or laser intervention once established

  • Progressive persistent redness: blood vessels become permanently dilated and redness no longer resolves between episodes
  • Rhinophyma: progressive nose enlargement and distortion from tissue overgrowth, primarily in men
  • Ocular complications: chronic blepharitis, dry eye, corneal erosion, and rarely vision impairment
  • Inflammatory papules and pustules: increasingly frequent and persistent without treatment
  • Depression and anxiety: significantly elevated due to the visible nature of facial rosacea
  • [Rare] Corneal perforation: advanced untreated ocular rosacea can cause severe corneal damage

How Can You Live Well With Rosacea?

Living well with rosacea means building a gentle skincare routine, identifying and avoiding your personal triggers, using prescribed treatments consistently, and addressing the emotional impact of living with a visible skin condition. With proper management, most people with rosacea can achieve significant symptom control.

Your skincare routine is your daily defense against rosacea flares. Use a gentle cream cleanser (avoid foaming cleansers), apply a ceramide-based moisturizer, and always wear mineral sunscreen (zinc oxide or titanium dioxide) with SPF 30 or higher — sun exposure is the number one rosacea trigger according to the National Rosacea Society. Introduce new products one at a time with a two-week trial period, and avoid alcohol-based toners, fragrant products, menthol, witch hazel, and physical exfoliants.

Temperature and environmental management can significantly reduce flare frequency. Avoid hot beverages (let coffee and tea cool first), limit spicy foods and alcohol (especially red wine), dress in layers to prevent overheating, and protect your face from cold wind with a soft scarf. During exercise, choose lower-intensity activities, exercise in cool environments, and mist your face with cold water during workouts.

The emotional impact of rosacea deserves acknowledgment and support. A National Rosacea Society survey found that 90 percent of patients reported lowered self-esteem and self-confidence, and 41 percent reported avoiding social situations. If rosacea is affecting your mental health, talk to your dermatologist about optimizing treatment and consider connecting with the National Rosacea Society community resources.

What Questions Should You Ask Your Doctor About Rosacea?

Preparing targeted questions for your dermatology visit helps you develop an effective, personalized management plan for your specific rosacea subtype. Here are the most important questions, along with why each one matters.

Rosacea management is highly individual — what works for one person may not work for another. Your dermatologist can help you navigate the options and create a plan tailored to your subtype, triggers, and treatment goals.

  • Which rosacea subtype do I have, and does my treatment target that specific type? -- Different subtypes respond to different treatments; papulopustular rosacea needs anti-inflammatory therapy while erythematotelangiectatic rosacea benefits from vascular-targeting treatments
  • Would laser or IPL therapy help my persistent redness and visible blood vessels? -- Laser treatments can provide lasting reduction of telangiectasia that topical medications cannot achieve
  • Should I be screened for ocular rosacea? -- Up to 50% of rosacea patients have eye involvement, and early treatment prevents corneal damage
  • Is my current skincare routine safe for rosacea, or are any products potentially triggering flares? -- Many common skincare ingredients irritate rosacea-prone skin without patients realizing the connection
  • Could my rosacea be related to Demodex mites, and would ivermectin cream help? -- Ivermectin targets Demodex overpopulation and has shown superior efficacy to metronidazole in clinical trials